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and where extracellular stimuli can interact with GPCR 
ligand binding domains. Recently, however, numerous 
GPCRs have also been found to be associated with vari-
ous intracellular membranes where, in certain cases, they 
activate intracellular signaling machinery leading to unique 
functional responses [1–11 ]. One such receptor is the 
metabotropic glutamate receptor, mGluR5, which is highly 
expressed on intracellular membranes including the ER and 
nuclear membranes throughout the CNS [12 , 13]. End g-
enous nuclear mGluR5 couples to Gq and PLC to generate 
IP3-mediated Ca
2+ release within the nucleus and activation 
of intracellular mGluR5 generates unique Ca2+ responses 
as well as downstream signaling cascades distinct from cell 
surface counterparts, [14 , 15]. These observations and those 
by others challenge the notion that cells only interact with 
their environment at the plasma membrane to bring about 
long term changes.
The question arises then as to what ligand activates 
intracellular mGluR5 and mechanistically how activation 
is achieved. The most parsimonious answer is that as the 
natural ligand, glutamate itself may activate intracellular 
mGluR5. Glutamate uptake is mediated by at least five 
sodium-dependent transporter proteins that are present on 
glial and neuronal cells as well as the chloride-dependent 
cystine-glutamate exchanger [16–21 ]. Previous data show 
that both of these uptake systems are responsible for trans-
porting glutamate into striatal, hippocampal and/or spinal 
cord dorsal horn neurons to activate mGluR5 [13, 22–24]. 
Conditions that block the transporters (i.e., chloride-free 
buffers and the compound l-cystine for the cystine/gluta-
mate exchanger; sodium free buffers and the compound, 
threo-β-benzyloxyaspartate for sodium-dependent excit-
atory amino acid transporters) reduce agonist uptake in 
mGluR5-expressing neurons [13, 22–24]. Moreover, 
uptake of radiolabeled quisqualate, an mGluR5 agonist, and 
Abstract The group 1 metabotropic glutamate receptor, 
mGluR5, is found on the cell surface as well as on intracel-
lular membranes where it can mediate both overlapping and 
unique signaling effects. Previously we have shown that gluta-
mate activates intracellular mGluR5 by entry through sodium-
dependent transporters and/or ystine glutamate exchangers. 
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Introduction
Signal transduction from G protein coupl d receptors 
(GPCRs) has traditionally been thought to e nate from the 
cell surface where many signaling complexes are clustered 
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imaged and quantitated as described [13, 15, 26]. Glutamate 
(Sigma-Aldrich, St. Louis, MO) was added at various con-
centrations in the presence of D-(-)-2-Amino-5-phosphono-
pentanoic acid (APV, NMDA receptor antagonist, 100 μM, 
Tocris); 6-Cyano-7-nitroquinoxaline-2,3-dione (CNQX, 
AMPA/Kainate receptor antagonist, 20 μM, Tocris); (2S)-
2-Amino-2-[(1S,2S)-2-carboxycycloprop-1-yl]-3-(xanth-
9-yl) propanoic acid (LY341495, Group 2/3 mGluR 
antagonist, 100 nM, Tocris); and 7-(Hydroxyimino)
cyclopropa[b]chromen-1a-carboxylate ethyl ester (CPC-
COEt, mGluR1 antagonist, 20 μM, Tocris) to detect mGluR5 
specific Ca2+ responses.
Fluorescence-Based Ca2+ Flux Ass y with Microplate 
Reader
Primary striatal cultures (Div11–15) plated in 96-well plates 
were loaded with 1 μM Fura-2 AM (Molecular Probes) for 
30 min at 37 °C and washed with Hanks’ balanced salt solu-
tion (HBSS). The cells were then preincubated with APV 
(100 μM), CNQX (20 μM), LY341495 (100 nM), CPCCOEt 
(20 μM), and the impermeable, nontransported mGluR5 
antagonist 3-[(1S)-1-amino-1-carboxy-2-(9H-thioxanthen-
9-yl)ethyl]cyclobutane-1-carboxylic acid, (LY393053, 
20 μM, Eli Lilly, Indianapolis, IN) in HBSS for 20 min at 
37 °C prior to measure intracellular mGluR5 specific Ca2+ 
flux. Fura-2 fluorescence was measured using a BioTek™ 
Synergy™ H4 Hybrid Microplate Reader (BioTek, Win-
ooski, VT). The baseline 340/380 nm excitation ratio for 
fura-2 was collected for 5 s before injecting various concen-
tration of glutamate. Data were collected for an additional 
30 s and then analyzed using Biotek’s Gen5 analysis soft-
ware. The dose-response curves were fit using the GraphPad 
Prism 3.0 program (Graphpad Software, San Diego, CA).
Caged Glutamate Experiments
DIV11–15 striatal cultures were loaded with Oregon green 
BAPTA-1 AM (Molecular Probes, Eugene, OR) as described 
[13 ]. Cells were microinjected with fluoro-ruby (3.2 mg/
ml, Molecular Probes) and 20 mM 4-M thoxy-7-nitroin-
dolinyl-caged-l-glutamate (MNI-caged-glutamate, Tocris, 
Avonmouth, Bristol, United Kingdom) using the single cell 
electroporator, Axoporator 800A (Molecular Devises, Silicon 
Valley, CA). Alternatively, MNI-caged glutamate was bath 
applied to the cells at a concentration of 200 μM. Cells were 
kept at 37 °C and imaged on an Olympus FluoView™ FV1000 
confocal microscope with a SIM scanner. Photo-uncaging 
was performed using 405 nm laser with Tornado scanning 
within the region of interest (ROI) for 500 ms. Wh  indi-
cated, the following antagonists were used at the indicated 
concentration: APV (100 μM); CNQX (20 μM); LY341495 
(100 nM); CPCCOEt (20 μM), LY393053 (20 μM) and 
glutamate is also observed in isolated nuclei, which c n be 
blocked with chloride-free buffers or by applying the s me 
transporter blockers. Thus, 90–95 % of all ligand-induced 
intracellular responses can be ccounted for by these ligand 
transport processes [13, 22–24].
Besides mechanisms by which glutamate ca  enter the cell, 
another limitation to the not on that endogenous ligand can 
activate intracellular mGluR5 is the idea that cytoplasmic glu-
tamate concentrations are in he mM range. Indeed, 10 mM is 
frequently used as the concentrati n of cytoplasmic glutamate 
with levels ranging up to 100–200 mM within vesicles [25]. If 
cytoplasmic glutamate concentrations are indeed 10 mM then 
an intracellular glutamate receptor would be maximally acti-
vated or possibly desensitized long before a new bolus of glu-
tamate entered the cell. To addr ss these issues we have used 
cellular, optical and molecular techniques to determine the (1) 
intracellular localization of glutamate; (2) concentrations nec-
essary to activate cell surface and intracel lar mGluR5; and 
(3) the effects of uncaging caged glutamate with n neurons.
Materials and Methods
Cell Culture and Transfection
Primary cultures of striatal neurons were prepared from post-
natal day 1 rat pups as previously d scribed [13]. The cell  
were plated onto 12-mm poly-d-lysine-coated glass cover-
slips (60,000/coverslip) for immunostaining or Ca2+ imag-
ing. Cells were cultured in humidified air with 5 % CO2 at 
37 °C for 11–15 days before use. For experiments using the 
microplate reader, cultures wer plated at 40,000 cells per 
well in black-walled, clear-bott m d 96-well plates and then 
cultured as above. Striatal cultures we e transfected with 
plasmid mito-eYFP (gift from Dr. Ian Reynolds; Department 
of Pharmacology, University of Pittsburgh, Pittsburgh, Penn-
sylvania) using lipofectamine 2000 (Invitrogen, Carlsbad, 
CA) on DIV 9 and then immunostained on DIV 10.
Immunocytochemistry
Striatal cultures were fixed, blocked, and incubated as 
described [13]. Primary antibodies include mouse anti-
glutamate (1:5000; ImmunoStar, Inc., Huds n, WI) and 
goat anti-HSP60 (1:100; Santa Cruz Biotechnology, Santa 
Cruz, CA). Secondary antibodies include goat anti-mouse 
Cy3 and donkey anti-goat Alexa 488 (1:300, Jackson Immu-
noResearch, West Grove, PA).
Fluorescent Measurements of Intracellular Ca2+
DIV 11–15 striatal neurons grown o  coverslips were loaded 
with Ca2+ fluorophore Oregon Green 488 BAPTA-1 AM, 
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neurons, we transfected cultures with mito-YFP to label 
mitochondria and then fixed and stained for glutamate. In 
support of EM studies showing anti-glutamate immuno-
gold particles over mitochondria [30 ], immunofluorescence 
showed anti-glutamate co-localized with mito-YFP in stria-
tal cell bodies and processes (Fig. 1a). In addition, cultures 
stained with HSP60, a marker of mitochondria as well as 
anti-glutamate also showed co-localization (Fig. 1b). Thus 
the majority of immunoreactive glutamate within these 
GABA-ergic neurons is compartmentalized in mitochondria.
“Location” Bias Apparent in Receptor-Mediated  
Ca2+ Responses
Earlier studies [15 ] showed no significant differences in glu-
tamate binding at receptors prepared from striatal plasma 
membrane or intracellular membrane sources. Those stud-
ies, however, did not address location-specific receptor 
responses in terms of function. Therefore, we used real 
time Ca2+ imaging to determine half-maximal glutamate 
2-Methyl-6-(phenylethynyl)pyridine (MPEP, 10 μM, Tocris). 
Calcium responses in the ROI and co rol reas were ana-
lyzed using MetaMorph software (Molecular Devises).
Results
Glutamate is Sequestered in Ne ronal Mito hondria
Previous studies using techniqu s uch as 13 C-NMR, 
13 C- and/or 15N-GC/MS have provided compelling evidence 
that glutamate has many fates within the cell. For example, 
a large proportion of glutam te is taken up by the mitochon-
dria where it is transaminated and serves as a substrate for 
the TCA cycle [27 , 28]. Indeed, anti-glutamate immu o old 
electron microscopy studies indicate that particles repre-
senting glutamate are clust red over m tochondria as well 
as the nucleus [29]. W  have previously shown th t mGluR5 
is highly expressed in GABA-e gic striatal neurons [13]. To 
determine whether glutamate could be visualized in striatal 
Fig. 1 Intracellular glutamate pools are predominantly localized in 
mitochondria. a Glutamate co-localizes with mitochondrial-targeted 
YFP. Cultured striatal neurons were transfected with mito-YFP (green) 
and stained with anti-glutamate (red). b Colocalization of gluta ate 
(red) with the mitochondrial marker, HSP60 (green). For a, bmagni-
fied images of boxed area in upper panels are shown below (Color 
figure online)
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couple to PLC to induce release of Ca2+ from intr c llular 
stores [24]. Here, we used this assay to show that the half 
maximal glutamate concentration for intracellular mGluR5 
is 61.3 ± 20.3 μM (Fig. 2d). Presumably, the increased EC50
value associated with intracellular mGluR5 reflects proper-
ties of the uptake mechanisms involved in glutamate trans-
port into the cell [13, 15]. Collectively, these data show that 
intracellular, striatal mGluR5 can function independently 
of signals originating at the cell surface and thus plays a 
dynamic role in mobilizing Ca2+ in a specific, localized 
manner. In addition these data emphasize that intracellular 
receptors can be activated with glutamate concentrations far 
lower than the putative intracellular cytoplasmic concentra-
tion, consistent with the notion that glutamate is sequestered 
in the cell.
Selective Uncaging of Glutamate Activates Intracellular 
mGluR5 Within the Cell and in the Dendrites
To further demonstrate that glutamate activates intracellu-
lar mGluR5, we electroporated caged glutamate (MNI-Glu) 
into individual neurons along with fluoro-ruby to tag recipi-
ent cells. Following electroporation, cultures were loaded 
concentrations associated with the plasma membrane or 
intracellular mGluR5-mediated Ca2+ responses. As shown 
previously [15], glutamate-mediated Ca2+ changes con-
sisted of two phases, an in tial rapi  rise followed by a sus-
tained elevation (Fig. 2a, red trace). Both sets of responses 
were terminated by the addition of the permeable mGluR5 
antagonist, MPEP, whereas cultures pretreated with the 
impermeable, nontransported antagonist LY393053, only 
exhibited a sustained Ca2+ re pons  pattern (not shown). As 
shown previously, LY393053 by itself had no effect on Ca2+ 
responses in striatal cultur s [13–15]. In contrast, ad tion 
of the nontransported agonist, DHPG, led to  rapid tran-
sient Ca2+ peak (Fig. 2a, blue trace), which could be blocked 
by LY393053 (not shown). The half-maximal glutamate 
concentration to stimulate a rapid transient Ca2+ response 
(cell surface) is 2.21 ± 0.8 μM (Fig. 2b) whereas the half-
maximal concentration to induce a sustained plateau Ca2+
response (intracellular; [15]) is 21.4 ±4.0 μM (Fig. 2c).
To extend these results, we used a fluorescence-based 
Ca2+ flux plate-reader assay in which cells were loaded with 
the ratiometric Ca2+ indicato  Fura-2 AM before Ca2+ flux 
measurement. Previously we used this ssay system to show 
that mGluR5-expressing spinal cord dorsal horn n urons 
Fig. 2 Half-maximal glutamate concentrations associated with intra-
cellular mGluR5-mediated Ca2+ r sponses in striatal neurons. a–c DIV 
11–15 striatal neurons grown on coverslips were loaded with Ca2+ flu-
orophore Oregon Green 488 BAPTA-1 AM and imaged. a Glutamate 
dose-dependency in Ca2+ responses; only a single transient peak (blue) 
is observed at glutamate doses below 5 μM whereas both transient and 
sustained peaks (red) are seen with higher glutamate concentrations. b 
The EC50 glutamate concentration to stimulate a rapid transient Ca
2+ 
response (cell surface) is 2.21 ± 0.8 μM. Error bars rep esent SEM. 
(N = 3). c The EC50 glutamate concentration to induce a sustained Ca2+ 
response (intracellular) is 21.4 ± 4.0 μM, Error bars rep esent SEM. 
(N = 3).d DIV 11–15 triatal neurons plated on 96-well plates were 
loaded with fura-2 AM for Ca2+ flux plate reader assay. The b seline 
340/380 nm excitation ratio for fura-2 was collected for 5 s before 
injecti g wi h v rious concentrations of glutamate. Data were normal-
ized to a glutamate (2 mM) control maximum. Concentration-response 
c rves were generated from the mean data of three experiments. Error 
bars repres nt SEM. The EC50 glutamate co centration for intracel-
lular mGluR5 is 61.3 ± 20.3 μM (Color figure online)
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in fluorescence whereas the surrounding regions did not 
(Fig. 3c, d). MPEP blocked all Ca2+ responses (not shown). 
These data emphasize the notion that some of the signaling 
originates in the ER, an organelle not easily assayed other 
than using the selective tools described here. Thus akin to 
results in the hippocampus [23], our findings indicate that 
activation of dendritic, intracellular mGluR5 also leads to 
in situ Ca2+ ch nges with neither input to nor output from 
the cell soma.
Discussion
In addition to functioning as a neurotransmitter, glutamate 
serves many metabolic roles within the cell such as acting 
as a building block for protein synthesis, playing a role in 
energy metabolism, and transferring reducing equivalents 
from the cytoplasm to the mitochondria [31]. Giv n these 
myriad tasks, it is not surprising that intracellular glutamate 
concentrations are thought to be in the mM range. Contrary 
to this notion, here we show that glutamate is largely com-
partmentalized in mitochondria, at least in striatal neurons. 
with Oregon Green BAPTA-1 AM and p eincuba ed w th 
LY393053 as well as ionotropic re eptor (NMDA, AMPA, 
and kainate receptors), mGluR1, nd Groups 2 and 3 mGluR 
antagonists prior to uncaging a ROI (Fig. 3a). Only neu-
ronal somas subjected to laser-induced photolys s (uncag-
ing) showed mGluR5-mediated Ca2+ changes (Fig. 3b; red 
trace), neuronal somas withou  uncaging showed no change 
in Ca2+ responses (Fig. 3b; blue trace). These data demon-
strate that releasing glutamate within the cell can activate 
intracellular mGluR5.
Because ultrastructure studies have also shown large 
numbers of mGluR5 gold particles on endoplasmic retic-
ulum (ER) membranes [12], we tested whether mGluR5 
expressed on dendritic ER or en osomal membranes can 
mediate local Ca2+ rises. To do so intrac llular r ceptors
were pharmacologically isolated by blocking cell surface
mGluR5 with LY393053 as well as mGluR1, iono ropic and 
Group 2/3 mGluR targets. In addition to the antagonis s, the 
extracellular buffer also cont ined MNI-glutamate which 
was uncaged in an ROI on a striatal dendrite at least 20 μm 
away from the cell body (Fig. 3c). Only the region of the 
dendrite juxtaposed to the unc gi g spot exhibit d a change 
Fig. 3 Regionally selective uncaging of glutamate in the presence of 
cell surface inhibitors activates intracellular mGluR5 in striatal soma 
(a, b) and dendrites (c, d). a, bStriatal neurons were injected with 
fluoro-ruby and MNI-caged-glutamate. Uncaging of MNI-glutamate 
at a somal ROI induced a Ca2+ rise at the red ROI whereas no Ca2+
changes were seen at the bluROI (N = 5). c, dMNI-caged glutamate 
was bath applied to striatal cultures at a concentration of 200 µM. 
MNI-glutam te was uncaged on a striatal dendrite at the r d ROI in 
the presence of LY53 (20 µM), the NMDA receptor b ocker APV 
(100  µM), th  AMPA/Kainate receptor blocker CNQX (20 µM), the 
mGluR1 blocker CPCCOEt (20 µM) and the Group 2/3 mGluR antag-
onist LY341495 (100nM). Uncaged glutamate generated a Ca2+ rise at 
the redROI whereas no Ca2+ changes were seen in a different neurite 
in the same field (white arrows) (N = 10) (Color figure online)
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and regulation of the many enzymes involved in its produc-
tion will also play an important role in receptor activation.
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